Patents by Inventor Vladyslav Soroka

Vladyslav Soroka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MALARIA VACCINE AND METHODS FOR PRODUCING SAME
    Publication number: 20210268093
    Abstract: The present description relates to malaria vaccines comprising Plasmodium falciparum (Pf) polypeptide complexes and methods of producing the same. The Pf polypeptides in complexes or in a partially complexed arrangement may comprise two or more of the following polypeptides: PfRipr, PfCyrPa and PfRh5. Drosophila cells and expression vectors are also described.
    Type: Application
    Filed: February 12, 2021
    Publication date: September 2, 2021
    Inventors: Alan Cowman, Julie Healer, Willem Adriaan De Jongh, Teit Max Moscote Sogaard, Thomas Dan Jorgensen, Vladyslav Soroka
  • Malaria vaccine and methods for producing same
    Patent number: 10940190
    Abstract: The present description relates to malaria vaccines comprising Plasmodium falciparum (Pf) polypeptide complexes and methods of producing the same. The Pf polypeptides in complexes or in a partially complexed arrangement may comprise two or more of the following polypeptides: PfRipr, PfCyrPa and PfRh5. Drosophila cells and expression vectors are also described.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: March 9, 2021
    Assignees: The Walter and Eliza Hall Institute of Medical Research, Expres2ion Biotechnologies
    Inventors: Alan Cowman, Julie Healer, Willem Adriaan De Jongh, Teit Max Moscote Sogaard, Thomas Dan Jorgensen, Vladyslav Soroka
  • A MALARIA VACCINE AND METHODS FOR PRODUCING SAME
    Publication number: 20200030427
    Abstract: The present description relates to malaria vaccines comprising Plasmodium falciparum (Pf) polypeptide complexes and methods of producing the same. The Pf polypeptides in complexes or in a partially complexed arrangement may comprise two or more of the following polypeptides: PfRipr, PfCyrPa and PfRh5. Drosophila cells and expression vectors are also described.
    Type: Application
    Filed: February 23, 2018
    Publication date: January 30, 2020
    Inventors: Alan Cowman, Julie Healer, Willem Adriaan De Jongh, Teit Max Moscote Sogaard, Thomas Dan Jorgensen, Vladyslav Soroka
  • Method of modulating cell survival, differentiation and/or synaptic plasticity
    Patent number: 7847058
    Abstract: The present invention relates to a method of modulating differentiation, adhesion and/or survival of the neural cell adhesion molecule (NCAM) presenting cells by providing compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM. The invention provides candidate compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM by using methods for screening and testing described in the application. The invention further relates to pharmaceutical compositions comprising compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM and to use of the pharmaceutical compositions and compounds for the modulation of differentiation, adhesion and/or survival of NCAM presenting cells.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: December 7, 2010
    Inventors: Elisabeth Bock, Vladimir Berezin, Vladyslav Soroka, Christina Kasper, Jette Sandholm Jensen Kastrup
  • Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity
    Publication number: 20080249004
    Abstract: The present invention relates to a method of modulating differentiation, adhesion and/or survival of the neural cell adhesion molecule (NCAM) presenting cells by providing compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM. The invention provides candidate compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM by using methods for screening and testing described in the application. The invention further relates to pharmaceutical compositions comprising compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM and to use of the pharmaceutical compositions and compounds for the modulation of differentiation, adhesion and/or survival of NCAM presenting cells.
    Type: Application
    Filed: September 29, 2004
    Publication date: October 9, 2008
    Applicant: ENKAM Pharmaceuticals A/S
    Inventors: Elisabeth Bock, Vladimir Berezin, Vladyslav Soroka